Pharmacy

Aug 7 2017

UPDATED: Daiichi Sankyo starts layoff drive with 16% cuts at HQ #core #pharma

#sankyo pharma # UPDATED: Daiichi Sankyo starts layoff drive with 16% cuts at HQ Times have been tough for Daiichi Sankyo, and they’re about to get tougher for some of the Japanese company’s U.S. staffers. The drugmaker is cutting its commercial headquarters staff by 16% on Monday, with more layoffs expected in mid-April. The cutbacks are part of a revamp at Daiichi’s U.S. business, based in Parsippany, NJ. The reasons for cutbacks are clear: Daiichi’s exclusivity on the cholesterol drug Welchol expires in June, and a bigger product–the blood pressure drug Benicar–loses its lock on the market next year. That …

Jul 22 2017

UPDATED: Daiichi Sankyo starts layoff drive with 16% cuts at HQ #am #pharma

#sankyo pharma # UPDATED: Daiichi Sankyo starts layoff drive with 16% cuts at HQ Times have been tough for Daiichi Sankyo, and they’re about to get tougher for some of the Japanese company’s U.S. staffers. The drugmaker is cutting its commercial headquarters staff by 16% on Monday, with more layoffs expected in mid-April. The cutbacks are part of a revamp at Daiichi’s U.S. business, based in Parsippany, NJ. The reasons for cutbacks are clear: Daiichi’s exclusivity on the cholesterol drug Welchol expires in June, and a bigger product–the blood pressure drug Benicar–loses its lock on the market next year. That …

Jul 12 2017

UPDATED: Chicago makes second run at Allergan, J – J, Purdue and others with painkiller lawsuit #pharmaceutical #companies #in #canada

#chicago pharmaceutical companies # UPDATED: Chicago makes second run at Allergan, J J, Purdue and others with painkiller lawsuit Opioid makers thought they had dodged a litigation bullet 6 months ago when a federal judge dismissed a lawsuit by the City of Chicago trying to hold them accountable for an “epidemic” of painkiller, and even heroin, abuse. But the city is being tenacious and has refiled lawsuits claiming 6 drugmakers overstated the claims of the drugs’ benefits while downplaying their risks. The second amended complaint was filed on Thursday in Chicago against Purdue Pharma, Teva Pharmaceutical Industries ($TEVA), Johnson Johnson’s …

Apr 27 2017

UPDATED: Daiichi Sankyo starts layoff drive with 16% cuts at HQ #pharma #executive

#sankyo pharma # UPDATED: Daiichi Sankyo starts layoff drive with 16% cuts at HQ Times have been tough for Daiichi Sankyo, and they’re about to get tougher for some of the Japanese company’s U.S. staffers. The drugmaker is cutting its commercial headquarters staff by 16% on Monday, with more layoffs expected in mid-April. The cutbacks are part of a revamp at Daiichi’s U.S. business, based in Parsippany, NJ. The reasons for cutbacks are clear: Daiichi’s exclusivity on the cholesterol drug Welchol expires in June, and a bigger product–the blood pressure drug Benicar–loses its lock on the market next year. That …

Apr 5 2017

UPDATED: Chicago makes second run at Allergan, J – J, Purdue and others with painkiller lawsuit #cafe #pharma #novartis

#chicago pharmaceutical companies # UPDATED: Chicago makes second run at Allergan, J J, Purdue and others with painkiller lawsuit Opioid makers thought they had dodged a litigation bullet 6 months ago when a federal judge dismissed a lawsuit by the City of Chicago trying to hold them accountable for an “epidemic” of painkiller, and even heroin, abuse. But the city is being tenacious and has refiled lawsuits claiming 6 drugmakers overstated the claims of the drugs’ benefits while downplaying their risks. The second amended complaint was filed on Thursday in Chicago against Purdue Pharma, Teva Pharmaceutical Industries ($TEVA), Johnson Johnson’s …

Mar 31 2017

UPDATED: Daiichi Sankyo starts layoff drive with 16% cuts at HQ #medicinal #chemistry

#sankyo pharma # UPDATED: Daiichi Sankyo starts layoff drive with 16% cuts at HQ Times have been tough for Daiichi Sankyo, and they’re about to get tougher for some of the Japanese company’s U.S. staffers. The drugmaker is cutting its commercial headquarters staff by 16% on Monday, with more layoffs expected in mid-April. The cutbacks are part of a revamp at Daiichi’s U.S. business, based in Parsippany, NJ. The reasons for cutbacks are clear: Daiichi’s exclusivity on the cholesterol drug Welchol expires in June, and a bigger product–the blood pressure drug Benicar–loses its lock on the market next year. That …

Mar 24 2017

UPDATED: Chicago makes second run at Allergan, J – J, Purdue and others with painkiller lawsuit #top #drug #companies

#chicago pharmaceutical companies # UPDATED: Chicago makes second run at Allergan, J J, Purdue and others with painkiller lawsuit Opioid makers thought they had dodged a litigation bullet 6 months ago when a federal judge dismissed a lawsuit by the City of Chicago trying to hold them accountable for an “epidemic” of painkiller, and even heroin, abuse. But the city is being tenacious and has refiled lawsuits claiming 6 drugmakers overstated the claims of the drugs’ benefits while downplaying their risks. The second amended complaint was filed on Thursday in Chicago against Purdue Pharma, Teva Pharmaceutical Industries ($TEVA), Johnson Johnson’s …

Feb 11 2017

UPDATED: Daiichi Sankyo starts layoff drive with 16% cuts at HQ #generic #pharmaceutical

#sankyo pharma # UPDATED: Daiichi Sankyo starts layoff drive with 16% cuts at HQ Times have been tough for Daiichi Sankyo, and they’re about to get tougher for some of the Japanese company’s U.S. staffers. The drugmaker is cutting its commercial headquarters staff by 16% on Monday, with more layoffs expected in mid-April. The cutbacks are part of a revamp at Daiichi’s U.S. business, based in Parsippany, NJ. The reasons for cutbacks are clear: Daiichi’s exclusivity on the cholesterol drug Welchol expires in June, and a bigger product–the blood pressure drug Benicar–loses its lock on the market next year. That …

Feb 6 2017

UPDATED: Chicago makes second run at Allergan, J – J, Purdue and others with painkiller lawsuit #pharmaceutical #rep

#chicago pharmaceutical companies # UPDATED: Chicago makes second run at Allergan, J J, Purdue and others with painkiller lawsuit Opioid makers thought they had dodged a litigation bullet 6 months ago when a federal judge dismissed a lawsuit by the City of Chicago trying to hold them accountable for an “epidemic” of painkiller, and even heroin, abuse. But the city is being tenacious and has refiled lawsuits claiming 6 drugmakers overstated the claims of the drugs’ benefits while downplaying their risks. The second amended complaint was filed on Thursday in Chicago against Purdue Pharma, Teva Pharmaceutical Industries ($TEVA), Johnson Johnson’s …

Jan 25 2017

UPDATED: Daiichi Sankyo starts layoff drive with 16% cuts at HQ #taro #pharma

#sankyo pharma # UPDATED: Daiichi Sankyo starts layoff drive with 16% cuts at HQ Times have been tough for Daiichi Sankyo, and they’re about to get tougher for some of the Japanese company’s U.S. staffers. The drugmaker is cutting its commercial headquarters staff by 16% on Monday, with more layoffs expected in mid-April. The cutbacks are part of a revamp at Daiichi’s U.S. business, based in Parsippany, NJ. The reasons for cutbacks are clear: Daiichi’s exclusivity on the cholesterol drug Welchol expires in June, and a bigger product–the blood pressure drug Benicar–loses its lock on the market next year. That …

Nov 24 2016

UPDATED: Chicago makes second run at Allergan, J – J, Purdue and others with painkiller lawsuit #ranbaxy #pharma

#chicago pharmaceutical companies # UPDATED: Chicago makes second run at Allergan, J J, Purdue and others with painkiller lawsuit Opioid makers thought they had dodged a litigation bullet 6 months ago when a federal judge dismissed a lawsuit by the City of Chicago trying to hold them accountable for an “epidemic” of painkiller, and even heroin, abuse. But the city is being tenacious and has refiled lawsuits claiming 6 drugmakers overstated the claims of the drugs’ benefits while downplaying their risks. The second amended complaint was filed on Thursday in Chicago against Purdue Pharma, Teva Pharmaceutical Industries ($TEVA), Johnson Johnson’s …

Nov 21 2016

UPDATED: Daiichi Sankyo starts layoff drive with 16% cuts at HQ #pharma #guidelines

#sankyo pharma # UPDATED: Daiichi Sankyo starts layoff drive with 16% cuts at HQ Times have been tough for Daiichi Sankyo, and they’re about to get tougher for some of the Japanese company’s U.S. staffers. The drugmaker is cutting its commercial headquarters staff by 16% on Monday, with more layoffs expected in mid-April. The cutbacks are part of a revamp at Daiichi’s U.S. business, based in Parsippany, NJ. The reasons for cutbacks are clear: Daiichi’s exclusivity on the cholesterol drug Welchol expires in June, and a bigger product–the blood pressure drug Benicar–loses its lock on the market next year. That …

Nov 14 2016

UPDATED: Chicago makes second run at Allergan, J – J, Purdue and others with painkiller lawsuit #ranbaxy #pharma

#chicago pharmaceutical companies # UPDATED: Chicago makes second run at Allergan, J J, Purdue and others with painkiller lawsuit Opioid makers thought they had dodged a litigation bullet 6 months ago when a federal judge dismissed a lawsuit by the City of Chicago trying to hold them accountable for an “epidemic” of painkiller, and even heroin, abuse. But the city is being tenacious and has refiled lawsuits claiming 6 drugmakers overstated the claims of the drugs’ benefits while downplaying their risks. The second amended complaint was filed on Thursday in Chicago against Purdue Pharma, Teva Pharmaceutical Industries ($TEVA), Johnson Johnson’s …

Nov 11 2016

UPDATED: Daiichi Sankyo starts layoff drive with 16% cuts at HQ #victory #pharma

#sankyo pharma # UPDATED: Daiichi Sankyo starts layoff drive with 16% cuts at HQ Times have been tough for Daiichi Sankyo, and they’re about to get tougher for some of the Japanese company’s U.S. staffers. The drugmaker is cutting its commercial headquarters staff by 16% on Monday, with more layoffs expected in mid-April. The cutbacks are part of a revamp at Daiichi’s U.S. business, based in Parsippany, NJ. The reasons for cutbacks are clear: Daiichi’s exclusivity on the cholesterol drug Welchol expires in June, and a bigger product–the blood pressure drug Benicar–loses its lock on the market next year. That …

Nov 7 2016

UPDATED: Chicago makes second run at Allergan, J – J, Purdue and others with painkiller lawsuit #axcan #pharma

#chicago pharmaceutical companies # UPDATED: Chicago makes second run at Allergan, J J, Purdue and others with painkiller lawsuit Opioid makers thought they had dodged a litigation bullet 6 months ago when a federal judge dismissed a lawsuit by the City of Chicago trying to hold them accountable for an “epidemic” of painkiller, and even heroin, abuse. But the city is being tenacious and has refiled lawsuits claiming 6 drugmakers overstated the claims of the drugs’ benefits while downplaying their risks. The second amended complaint was filed on Thursday in Chicago against Purdue Pharma, Teva Pharmaceutical Industries ($TEVA), Johnson Johnson’s …

Oct 29 2016

UPDATED: Chicago makes second run at Allergan, J – J, Purdue and others with painkiller lawsuit #digital #pharma

#chicago pharmaceutical companies # UPDATED: Chicago makes second run at Allergan, J J, Purdue and others with painkiller lawsuit Opioid makers thought they had dodged a litigation bullet 6 months ago when a federal judge dismissed a lawsuit by the City of Chicago trying to hold them accountable for an “epidemic” of painkiller, and even heroin, abuse. But the city is being tenacious and has refiled lawsuits claiming 6 drugmakers overstated the claims of the drugs’ benefits while downplaying their risks. The second amended complaint was filed on Thursday in Chicago against Purdue Pharma, Teva Pharmaceutical Industries ($TEVA), Johnson Johnson’s …

Oct 26 2016

UPDATED: Daiichi Sankyo starts layoff drive with 16% cuts at HQ #biotech

#sankyo pharma # UPDATED: Daiichi Sankyo starts layoff drive with 16% cuts at HQ Times have been tough for Daiichi Sankyo, and they’re about to get tougher for some of the Japanese company’s U.S. staffers. The drugmaker is cutting its commercial headquarters staff by 16% on Monday, with more layoffs expected in mid-April. The cutbacks are part of a revamp at Daiichi’s U.S. business, based in Parsippany, NJ. The reasons for cutbacks are clear: Daiichi’s exclusivity on the cholesterol drug Welchol expires in June, and a bigger product–the blood pressure drug Benicar–loses its lock on the market next year. That …

Sep 30 2016

UPDATED: Chicago makes second run at Allergan, J – J, Purdue and others with painkiller lawsuit #e #detailing #pharma

#chicago pharmaceutical companies # UPDATED: Chicago makes second run at Allergan, J J, Purdue and others with painkiller lawsuit Opioid makers thought they had dodged a litigation bullet 6 months ago when a federal judge dismissed a lawsuit by the City of Chicago trying to hold them accountable for an “epidemic” of painkiller, and even heroin, abuse. But the city is being tenacious and has refiled lawsuits claiming 6 drugmakers overstated the claims of the drugs’ benefits while downplaying their risks. The second amended complaint was filed on Thursday in Chicago against Purdue Pharma, Teva Pharmaceutical Industries ($TEVA), Johnson Johnson’s …

Sep 17 2016

UPDATED: Daiichi Sankyo starts layoff drive with 16% cuts at HQ

#sankyo pharma # UPDATED: Daiichi Sankyo starts layoff drive with 16% cuts at HQ Times have been tough for Daiichi Sankyo, and they’re about to get tougher for some of the Japanese company’s U.S. staffers. The drugmaker is cutting its commercial headquarters staff by 16% on Monday, with more layoffs expected in mid-April. The cutbacks are part of a revamp at Daiichi’s U.S. business, based in Parsippany, NJ. The reasons for cutbacks are clear: Daiichi’s exclusivity on the cholesterol drug Welchol expires in June, and a bigger product–the blood pressure drug Benicar–loses its lock on the market next year. That …